Cardiotrophin-1 administration protects from ischemia-reperfusion renal injury and inflammation

Transplantation

Volumn 96, Issue 12, 2013, Pages 1034-1042

  Garcia Cenador, María B ^a,b   Lorenzo Gomez, María F ^a,b   Herrero Payo, Julio J ^a   Ruiz, Juan ^c   Perez De Obanos, María P ^c   Pascual, Julio ^d   Lopez Novoa, José M ^a,e   Garcia Criado, Francisco J ^a,b  

^a UNIVERSITY OF SALAMANCA   (Spain)

^b INSTITUTO DE INVESTIGACIÓN BIOMÉDICA DE SALAMANCA IBSAL   (Spain)

^c Digna Biotech   (Spain)

^d HOSPITAL DEL MAR   (Spain)

^e Queen Sofía Institute for Renal Research   (Spain)

Author keywords

Acute kidney injury; Cardiotrophin 1; Inflammation; Ischemia; Kidney; Renal failure; Renal function

Indexed keywords

CARDIOTROPHIN 1; CREATININE; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA; UREA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; CYTOKINE RELEASE; DOWN REGULATION; GLOMERULUS FILTRATION RATE; KIDNEY INJURY; KIDNEY ISCHEMIA; LYMPHOCYTIC INFILTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RENAL PROTECTION; REPERFUSION INJURY; TREATMENT OUTCOME; UREA BLOOD LEVEL;

EID: 84891634418     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3182a74db4     Document Type: Article

References (45)

1. Agrawal M, Swartz R. Acute renal failure. Am Fam Phys 2000; 61: 2077.
2. Preston RA, Epstein M. Ischemic renal disease: an emerging cause of chronic renal failure and end-stage renal disease. J Hypertens 1997; 15: 1365.
3. Grinyo JM. Role of ischemia-reperfusion injury in the development of 'chronic renal allograft damage. Transplant Proc 2001; 33: 3741.
4. Eltzschig HK, Eckle T. Ischemia and reperfusionVfrom mechanism to translation. Nat Med 2011; 17: 1391.
5. Sharfuddin AA, Molitoris BA. Pathophysiology of ischemic acute kidney injury. Nat Rev Nephrol 2011; 7: 189.
6. Pennica D, King KL, Shaw KJ, et al. Expression cloning of cardiotrophin 1, a cytokine that induces cardiac myocyte hypertrophy. Proc Natl Acad Sci USA 1995; 92: 1142.
7. Stephanou A, Brar B, Heads R, et al. Cardiotrophin-1 induces heat shock protein accumulation in cultured cardiac cells and protects them from stressful stimuli. J Mol Cell Cardiol 1998; 30: 849.
8. Brar BK, Stephanou A, Liao Z, et al. Cardiotrophin-1 can protect cardiac myocytes from injury when added both prior to simulated ischaemia and at reoxygenation. Cardiovasc Res 2001; 51: 265.
9. Brar BK, Stephanou A, Pennica D, et al. CT-1 mediated cardioprotection against ischaemic re-oxygenation injury is mediated by PI3 kinase, Akt and MEK1/2 pathways. Cytokine 2001; 16: 93.
10. Liao Z, Brar BK, Cai Q, et al. Cardiotrophin-1 (CT-1) can protect the adult heart from injury when added both prior to ischaemia and at reperfusion. Cardiovasc Res 2002; 53: 902.
11. Hausenloy DJ, Yellon DM. Cardioprotective growth factors. Cardiovasc Res 2009; 83: 179.
12. Aoyama T, Takimoto Y, Pennica D, et al. Augmented expression of cardiotrophin-1 and its receptor component, gp130, in both left and right ventricles after myocardial infarction in the rat. J Mol Cell Cardiol 2000; 32: 1821.
13. Hishinuma S, Funamoto M, Fujio Y, et al. Hypoxic stress induces cardiotrophin-1 expression in cardiac myocytes. Biochem Biophys Res Commun 1999; 264: 436.
14. Iniguez M, Berasain C, Martinez-Anso E, et al. Cardiotrophin-1 defends the liver against ischemia-reperfusion injury and mediates the protective effect of ischemic preconditioning. J Exp Med 2006; 203: 2809.
15. Iniguez M, Dotor J, Feijoo E, et al. Novel pharmacologic strategies to protect the liver from ischemia-reperfusion injury. Recent Pat Cardiovasc Drug Discov 2008; 3: 9.
16. Aguilar-Melero P, Luque A, Machuca MM, et al. Cardiotrophin-1 reduces ischemia/reperfusion injury during liver transplant. J Surg Res 2013; 181: e83.
17. Peng H, Sola A, Moore J, et al. Caspase inhibition by cardiotrophin-1 prevents neuronal death in vivo and in vitro. J Neurosci Res 2010; 88: 1041.
18. Ló pez-Andrés N, Rousseau A, Akhtar R, et al. Cardiotrophin-1 is involved in cardiac, vascular, and renal fibrosis and dysfunction. Hypertension 2012; 60: 563.
19. Zolk O, Engmann S, Münzel F, et al. Chronic cardiotrophin-1 stimulation impairs contractile function in reconstituted heart tissue. Am J Physiol Endocrinol Metab 2005; 288: E1214.
20. Quiros Y, Sánchez-González PD, Ló pez-Hernández FJ, et al. Cardiotrophin-1 administration prevents the renal toxicity of iodinated contrast media in rats. Toxicol Sci 2013; 132: 493.
21. Goncalves S, Fernandez-Sanchez R, Sanchez-Nino MD, et al. Tyrphostins as potential therapeutic agents for acute kidney injury. Curr Med Chem 2010; 17: 974.
22. Terui K, Enosawa S, Haga S, et al. Stat3 confers resistance against hypoxia/reoxygenation-induced oxidative injury in hepatocytes through upregulation of Mn-SOD. J Hepatol 2004; 41: 957.
23. Jung JE, Kim GS, Chan PH. Neuroprotection by interleukin-6 is mediated by signal transducer and activator of transcription 3 and antioxidative signaling in ischemic stroke. Stroke 2011; 42: 3574.
24. Molitoris BA, Marrs J. The role of cell adhesion molecules in ischemic acute renal failure. Am J Med 1999; 106: 583.
25. Garcia-Criado FJ, Rodriguez-Barca P, Garcia-Cenador MB, et al. Protective effect of new nitrosothiols on the early inflammatory response to kidney ischemia/reperfusion and transplantation in rats. J Interferon Cytokine Res 2009; 29: 441.
26. Fritzenwanger M, Kuethe F, Haase D, et al. Cardiotrophin-1 induces monocyte chemoattractant protein-1 synthesis in human umbilical vein endothelial cells. Cytokine 2006; 33: 46.
27. Fritzenwanger M, Meusel K, Foerster M, et al. Cardiotrophin-1 induces interleukin-6 synthesis in human umbilical vein endothelial cells. Cytokine 2006; 36: 101.
28. Yoshidome H, Kato A, Edwards MJ, et al. Interleukin-10 suppresses hepatic ischemia/reperfusion injury in mice: implications of a central role for nuclear factor kappaB. Hepatology 1999; 30: 203.
29. Havasi A, Borkan SC. Apoptosis and acute kidney injury. Kidney Int 2011; 80: 29.
30. Ruixing Y, Dezhai Y, Jiaquan L. Effects of cardiotrophin-1 on hemodynamics and cardiomyocyte apoptosis in rats with acute myocardial infarction. J Med Invest 2004; 51: 29.
31. Ruixing Y, Jinzhen W, Dezhai Y, et al. Cardioprotective role of cardiotrophin-1 gene transfer in a murine model of myocardial infarction. Growth Factors 2007; 25: 286.
32. Zhou D, Zheng X, Wang L, et al. Expression and effects of cardiotrophin-1 (CT-1) in human airway smooth muscle cells. Br J Pharmacol 2003; 140: 1237.
33. Marques JM, Belza I, Holtmann B, et al. Cardiotrophin-1 is an essential factor in the natural defense of the liver against apoptosis. Hepatology 2007; 45: 639.
34. Craig R,Wagner M,McCardle T, et al. The cytoprotective effects of the glycoprotein 130 receptor-coupled cytokine, cardiotrophin-1, require activation of NF-kappa B. J Biol Chem 2001; 276: 37621.
35. Barnes PJ, Karin M. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 1997; 336: 1066.
36. Ghosh S, Hayden MS. New regulators of NF-kappaB in inflammation. Nat Rev Immunol 2008; 8: 837.
37. Xu S, Zhao Y, Yu L, et al. Rosiglitazone attenuates endothelial progenitor cell apoptosis induced by TNF-alpha via ERK/MAPK and NFkappaB signal pathways. J Pharmacol Sci 2011; 117: 265.
38. Grande MT, Perez-Barriocanal F, Lopez-Novoa JM. Role of inflammation in tubulo-interstitial damage associated to obstructive nephropathy. J Inflamm (Lond) 2010; 7: 19.
39. Terrell AM, Crisostomo PR, Wairiuko GM, et al. Jak/STAT/SOCS signaling circuits and associated cytokine-mediated inflammation and hypertrophy in the heart. Shock 2006; 26: 226.
40. Gonzalez A, Lopez B, Ravassa S, et al. Cardiotrophin-1 in hypertensive heart disease. Endocrine 2012; 42: 9.
41. Calabro P, Limongelli G, Riegler L, et al. Novel insights into the role of cardiotrophin-1 in cardiovascular diseases. J Mol Cell Cardiol 2009; 46: 142.
42. Garc?́a-Cenador MB, Lopez-Novoa JM, D?́ez J, et al. Effects and mechanism of organ protection by cardiotrophin-1. Curr Med Chem 2013; 20: 246.
43. Garcia-Criado FJ, Eleno N, Santos-Benito F, et al. Protective effect of exogenous nitric oxide on the renal function and inflammatory response in a model of ischemia-reperfusion. Transplantation 1998; 66: 982.
44. Rodriguez-Pena A, Garcia-Criado FJ, Eleno N, et al. Intrarenal administration of molsidomine, a molecule releasing nitric oxide, reduces renal ischemia-reperfusion injury in rats. Am J Transplant 2004; 4: 1605.
45. Grande MT, Fuentes-Calvo I, Arevalo M, et al. Deletion of H-Ras decreases renal fibrosis and myofibroblast activation following ureteral obstruction in mice. Kidney Int 2010; 77: 509.